Sudarshan Pharma Industries share price
BSE: 543828Chemicals & PetrochemicalsSmall Cap
Last close ₹31.25down ₹1.32 (4.05%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹32.57.
52-week range of traded prices to 23 Oct 2026
₹18.50Low, 29 Jan 2026₹42.79High, 21 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹795 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 31.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 4 Jun 2026
- 1.81
- Volume, BSEVolume. Shares traded on the last trading day.
- 40,000
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 12 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹174 Crdown 21.05%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹5.61 Crdown 50.76%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 3.2%
Revenue by year
Peak revenue ₹703 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Jun 2025Filed 14 Aug | Sep 2025Filed 18 Oct | Dec 2025Filed 28 Jan | Mar 2026Filed 30 Apr | Jun 2026Filed 12 Aug |
|---|---|---|---|---|---|
| Revenue | 145 | 169 | 168 | 221 | 174 |
| Net profit | 4 | 4 | 4 | 11 | 6 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 2.7% | 2.3% | 2.5% | 5.2% | 3.2% |
Consolidated. The 5 quarters from Jun 2025, the first on record; the half years before them are below. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
| ₹ crore | Sep 2024Filed 7 Dec | Mar 2025Filed 24 Apr |
|---|---|---|
| Revenue | 228 | 277 |
| Net profit | 6 | 10 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 2.6% | 3.6% |
Consolidated. The half years in the same span that the quarters on record do not fully cover.
Business segments
In the year to Mar 2026 the company reports one business segment, Chemicals And Solvents, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/B: the share count changed after the latest balance sheet (a rights issue, a buyback, an allotment or a listing), which does not yet hold the money it brought or returned. Not shown, EV/EBITDA: the share count changed after the latest balance sheet (a rights issue, a buyback, an allotment or a listing), which does not yet hold the money it brought or returned.PE ratio and valuation history
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 72% of 738 trading days over the last 3 years.
LowestHighest
Its median0.00%Industry median0.53%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −20.6% | +47.0% | −46.0% | 0.0% |
| 3 years | +63.2% | +21.0% | +34.9% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Peers and competitors
Specialty Chemicals, 130 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Sudarshan Pharma Industries in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Fairchem OrganicsFAIRCHEMOR | 937 | 39.4 | 3.3 | 21.1 | +17.4% | +292.5% | 8.3% | 10.4% | 0.13% |
 Indo AminesINDOAMIN | 888 | 11.0 | 2.3 | 8.2 | +13.2% | +23.1% | 22.8% | 17.2% | 0.41% |
 SacheeromeSACHEEROME | 888 | 31.2 | 6.0 | – | – | – | 19.2% | – | 0.00% |
 Sunshield ChemicalsSUNSHIEL | 847 | 23.4 | 3.4 | 13.9 | +13.1% | +108.7% | 20.9% | 19.4% | 0.31% |
 AmalAMAL | 724 | 24.3 | 5.1 | 17.6 | +96.8% | −23.1% | 23.4% | 22.3% | 0.26% |
 Chemcon Speciality ChemicalsCHEMCON | 724 | 25.7 | 1.5 | 15.6 | +17.4% | +10.6% | 5.7% | 4.7% | 3.29% |
 DMCC Speciality ChemicalsDMCC | 721 | 18.0 | 2.9 | 10.0 | +49.6% | +43.2% | 16.8% | 19.5% | 0.87% |
 Gem AromaticsGEMAROMA | 706 | – | 1.6 | 28.9 | – | – | −3.2% | −0.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Highest ₹0.03 a share, year to Mar 2023.
| Ex-date | Type | Per share |
|---|---|---|
| 25 Aug 2023 | Final | ₹0.30 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
23 Oct · Updates On Migration From SME Platform Of BSE To Capital Market Segment (Main Board) Of National Stock Exchange Of India Limited Of Sudarshan Pharma Industries Limited - Company Letter Bearing Ref. No. SPIL/CS/SE/2026-2027/20 Dated 21St May 2026
Sep 2026
Sudarshan Pharma Industries share price by year
Each calendar year to 2025.Sudarshan Pharma Industries share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 27.55 | −38.2% | 51.83 | 22.52 |
| 2024 | 44.59 | +448.5% | 44.59 | 6.31 |
| 2023 | 8.13 | – | 8.74 | 5.31 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 22 Mar 2023.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 32.57 | 33.00 | 31.20 | 31.25 | 31.85 | 40,000 |
| 22 Oct 2026 | 33.80 | 33.80 | 32.51 | 32.57 | 32.79 | 52,000 |
| 21 Oct 2026 | 35.20 | 35.20 | 33.61 | 33.80 | 34.32 | 64,000 |
| 19 Oct 2026 | 35.42 | 35.60 | 34.59 | 35.00 | 35.15 | 1,04,000 |
| 16 Oct 2026 | 35.20 | 36.99 | 35.06 | 36.40 | 36.29 | 72,000 |
| 15 Oct 2026 | 37.01 | 37.55 | 36.20 | 36.25 | 36.65 | 40,000 |
| 14 Oct 2026 | 37.99 | 37.99 | 36.51 | 36.74 | 37.16 | 72,000 |
| 13 Oct 2026 | 37.50 | 38.39 | 37.20 | 37.47 | 37.59 | 76,000 |
| 12 Oct 2026 | 37.98 | 38.71 | 36.60 | 38.71 | 37.56 | 24,000 |
| 9 Oct 2026 | 36.18 | 38.66 | 34.29 | 37.52 | 36.85 | 3,00,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 22 Nov 2024 | Split | 0.1000 | Each share became 10. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- Legal name
- SUDARSHAN PHARMA INDUSTRIES LIMITED
- BSE code
- 543828
- ISIN
- INE00TV01023
- Industry
- Chemicals & Petrochemicals
- Listed
- Mar 2023
- Face value
- ₹1
- CIN
- L51496MH2008PLC184997
- Corporate identity number, the registrar of companies' code for it